Table 2 Frequency of registries reporting use of EQ-5D data, per category of registry and category of use
|  | Reported use of EQ-5D data a | |||||||
|---|---|---|---|---|---|---|---|---|
Registries collecting EQ-5D data | Registries reporting use of EQ-5D data | Assessment of interventions | Health economic studies | Quality indicators | Benchmarking | Quality improvement | Use at individual level | |
| Â | n | n | n (% of registries using EQ-5D) | |||||
All registries | 41 | 22 | 10 (45) | 5 (23) | 10 (45) | 7 (32) | 6 (27) | 7 (32) |
Reported use by type of registry | ||||||||
| Â | n | n | n (% of registries using EQ-5D, within type of registry) | |||||
Diagnosis | 26 | 12 | 3 (25) | 3 (25) | 4 (33) | 2 (17) | 3 (25) | 5 (42) |
Intervention | 15 | 10 | 7 (70) | 2 (20) | 6 (60) | 5 (50) | 3 (30) | 2 (20) |
Reported use by registry category | ||||||||
| Â | n | n | n (% of registries using EQ-5D, within registry category) | |||||
Musculoskeletal system | 11 | 9 | 7 (78) | 1 (11) | 4 (44) | 4 (44) | 2 (22) | 2 (22) |
Neurological system | 9 | 4 | 1 (25) | 2 (50) | 1 (25) | 2 (50) | 3 (75) | 3 (75) |
Circulatory system | 7 | 3 | 1 (33) | 1 (33) | 2 (67) | 0 (0) | 0 (0) | 0 (0) |
Cancer | 3 | 1 | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) | 0 (0) |
Psychiatry | 3 | 1 | 0 (0) | 0 (0) | 1 (100) | 0 (0) | 0 (0) | 0 (0) |
Paediatrics | 2 | 2 | 0 (0) | 0 (0) | 1 (50) | 0 (0) | 1 (50) | 1 (50) |
Other areas | 2 | 2 | 1 (50) | 0 (0) | 1 (50) | 1 (50) | 0 (0) | 1 (50) |
Infection | 2 | 0 | – | – | – | – | – | – |
Endocrine organs | 1 | 0 | – | – | – | – | – | – |
Stomach and intestines | 1 | 0 | – | – | – | – | – | – |